Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01632696 · ClinicalTrials.gov registry record · Early Phase 1
Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors
A Early Phase 1 study, sponsored by Peregrine Pharmaceuticals.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 11
- Enrollment target
NCT01632696: Clinical Trial Early Phase 1 study, sponsored by Peregrine Pharmaceuticals.
NCT01632696 is a Early Phase 1 study that was terminated before completion, run by Peregrine Pharmaceuticals. The registered enrollment target is 11 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01632696, a Early Phase 1 study, was terminated before completion, sponsored by Peregrine Pharmaceuticals.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
Tumor Imaging of I-124 PGN65 in Solid Tumors
Interventions
- DRUG I-124 PGN650 for PET/CT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2012-06 |
| Est. Completion | 2016-05 |
| Phase | Early Phase 1 |
Why NCT01632696 stopped before completion
NCT01632696 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 1 intervention - of which I-124 PGN650 for PET/CT is the first listed.
NCT01632696 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01632696 about?
NCT01632696 is a clinical study titled "Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors". Tumor Imaging of I-124 PGN65 in Solid Tumors
What is the current status of trial NCT01632696?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 11 participants. The study started on 2012-06. Estimated completion is 2016-05.
What interventions are being tested in trial NCT01632696?
The interventions under investigation include: I-124 PGN650 for PET/CT (DRUG).
Who is sponsoring clinical trial NCT01632696?
This trial is sponsored by Peregrine Pharmaceuticals, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01632696's enrollment target sits among peer trials
11 1600th of 2000 higher than 373 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia